Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
product-based active compounds for the treatment of infectious diseases. PhD Student (m/f/div) in Bioprocess Engineering The position is initially limited to three years. We are looking for a person who is
-
irrespective of age, gender, disability, race, religion or ethnic background are encouraged to apply. As DTU works with research in critical technology, which is subject to special rules for security and export
-
. An individual career development plan containing research and transferable courses, international research visits, mentoring and career activities, is also a central element. Please visit https://www.interact
-
, the purpose for which your data will be processed, as well as further information about data protection is available to you on the website: https://tu-dresden.de/karriere/datenschutzhinweis .
-
. Information about the available topics and supervisors can be found under the following link: http://scads.ai/positions2025. The location of work (Dresden or Leipzig) depends on the topic assigned for each
-
(stamped arrival date of the university central mail service or the time stamp on the email server of TUD applies), preferably via the TUD SecureMail Portal https://securemail.tu-dresden.de by sending it as
-
Research Program RTG3120 on Biomolecular Condensates (https://dresdencondensates.org ). Each PhD project is part of an interdisciplinary framework that includes shared training activities, and supervision by
-
the application of female scientists. Additional information: Please submit your application until 7th January 2026, indicating the reference number 27635, via our online portal: Apply now! https://jobs.uksh.de/job
-
Declaration of interest regarding PhD project within the field of biomarker and therapeutic targe...
Department of Molecular Medicine at SDU is looking for applicants for a PhD scholarship within the field of biomarker and therapeutic target investigations in biliary atresia. We are looking for a
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed